They have a target, they bind to it, the target reacts, effects happen.
While they do that, it’s important to keep in mind that they frequently also bind other targets then the intended one’s.
When chosen molecules for clinical trials, pharma companies optimize them to bind better to the target and that often means that the molecule binds better in general.
While they do that, it’s important to keep in mind that they frequently also bind other targets then the intended one’s.
When chosen molecules for clinical trials, pharma companies optimize them to bind better to the target and that often means that the molecule binds better in general.